Harvard Bioscience, Inc. (HBIO)
NASDAQ: HBIO · Real-Time Price · USD
0.3706
+0.0185 (5.25%)
At close: May 13, 2025, 4:00 PM
0.4000
+0.0294 (7.93%)
Pre-market: May 14, 2025, 7:27 AM EDT

Harvard Bioscience Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
5.554.114.284.517.828.32
Upgrade
Cash & Short-Term Investments
5.554.114.284.517.828.32
Upgrade
Cash Growth
30.34%-4.09%-4.99%-42.36%-5.96%-0.22%
Upgrade
Accounts Receivable
13.4814.8716.116.7121.8317.77
Upgrade
Receivables
13.4814.8716.116.7121.8317.77
Upgrade
Inventory
22.8223.2524.7226.4427.5922.26
Upgrade
Other Current Assets
3.062.93.943.474.343.36
Upgrade
Total Current Assets
44.945.1249.0451.1261.5851.7
Upgrade
Property, Plant & Equipment
12.2911.248.759.1810.3111.72
Upgrade
Long-Term Investments
--3.5---
Upgrade
Goodwill
8.9656.3257.0756.2657.6958.59
Upgrade
Other Intangible Assets
10.1311.1316.0421.0127.3933.15
Upgrade
Long-Term Deferred Tax Assets
-0.090.440.330.210.26
Upgrade
Other Long-Term Assets
3.522.742.547.455.170.84
Upgrade
Total Assets
79.8126.64137.37145.36162.34156.25
Upgrade
Accounts Payable
4.814.795.556.454.915.97
Upgrade
Accrued Expenses
2.642.264.433.876.534.15
Upgrade
Current Portion of Long-Term Debt
35.9636.965.863.813.241.72
Upgrade
Current Portion of Leases
1.421.161.422.142.142.11
Upgrade
Current Income Taxes Payable
----0.220.29
Upgrade
Current Unearned Revenue
3.433.814.513.374.273.77
Upgrade
Other Current Liabilities
7.355.994.783.624.013.05
Upgrade
Total Current Liabilities
55.654.9626.5423.2525.3221.05
Upgrade
Long-Term Debt
--30.943.0145.146.29
Upgrade
Long-Term Leases
7.236.384.795.286.497.48
Upgrade
Long-Term Deferred Tax Liabilities
0.720.710.780.591.561.9
Upgrade
Other Long-Term Liabilities
1.421.261.281.010.491.26
Upgrade
Total Liabilities
64.9763.364.2973.1478.9479.57
Upgrade
Common Stock
0.440.440.430.450.450.44
Upgrade
Additional Paid-In Capital
237.1236.58232.44229.01225.65232.36
Upgrade
Retained Earnings
-208.35-158.01-145.61-142.19-132.67-132.39
Upgrade
Treasury Stock
------10.67
Upgrade
Comprehensive Income & Other
-14.36-15.67-14.19-15.05-10.03-13.07
Upgrade
Shareholders' Equity
14.8463.3473.0772.2283.476.68
Upgrade
Total Liabilities & Equity
79.8126.64137.37145.36162.34156.25
Upgrade
Total Debt
44.6144.542.9754.2456.9657.6
Upgrade
Net Cash (Debt)
-39.06-40.39-35.19-49.73-49.14-49.28
Upgrade
Net Cash Per Share
-0.89-0.93-0.83-1.20-1.22-1.28
Upgrade
Filing Date Shares Outstanding
44.2144.0743.442.1941.2339.83
Upgrade
Total Common Shares Outstanding
44.2144.0743.3942.0841.1439.41
Upgrade
Working Capital
-10.7-9.8422.527.8836.2730.65
Upgrade
Book Value Per Share
0.341.441.681.722.031.95
Upgrade
Tangible Book Value
-4.26-4.12-0.03-5.05-1.67-15.06
Upgrade
Tangible Book Value Per Share
-0.10-0.09-0.00-0.12-0.04-0.38
Upgrade
Machinery
-18.3615.9515.7115.318.02
Upgrade
Leasehold Improvements
-2.572.422.512.562.54
Upgrade
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q